ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02784483
Recruitment Status : Suspended
First Posted : May 27, 2016
Last Update Posted : January 9, 2018
Sponsor:
Information provided by (Responsible Party):
Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : June 2019